These data demonstrate that HAS infusions continued to restore the plasma-mediated inflammatory response as defined by macrophage TNF-α and IL10 production in AD/ACLF patients to healthy volunteer levels beyond day 3 as shown previously.6 The gene discussed is TNF; the disease is Alzheimer disease.